Press Releases

03.13.2024

Affini-T Therapeutics to Present Preclinical Data from its Programs Targeting KRAS G12D and p53 R175H and Two Trials in Progress at the American Association for Cancer Research (AACR) Annual Meeting

Press Releases

01.07.2024

Affini-T Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Press Releases

11.13.2023

Affini-T Therapeutics Appoints Healthcare Capital Markets Veteran Kathy Bergsteinsson, MBA, as Chief Financial Officer

Press Releases

10.31.2023

Affini-T Therapeutics to Present Preclinical Gene Editing Data from its Program Targeting KRAS G12D at the Society for Immunotherapy of Cancer (SITC) 38th Annual Meeting

Press Releases

View All

In The News
ENDPOINTS

06.02.2023

Exclusive: Affini-T taps Sanofi alum to lead hunt for partnerships; Alkermes locks in CEO for oncology spinout

News
ENDPOINTS

04.19.2023

KRAS, one of cancer’s toughest targets, sees a surge of new therapies trying to limit side effects: #AACR23

News
ENDPOINTS

11.28.2022

Endpoints’ 10 biggest stories of 2022

News
ENDPOINTS

09.22.2022

The Endpoints 11: The top private biotechs in pursuit of new drugs. Pushing the envelope with powerful new technologies

News

View All

Corporate Presentations

Corporate Presentation

View Presentation

11.03.2023

Society for Immunotherapy of Cancer (SITC) 38th Annual Meeting 2023, Poster #1233

Presentations

11.03.2023

Society for Immunotherapy of Cancer (SITC) 38th Annual Meeting 2023, Poster #355

Presentations

06.03.2023

American Society of Clinical Oncology Annual Meeting (ASCO) 2023, Poster Presentation #2543

Presentations

05.16.2023

American Society of Gene and Cell Therapy (ASGCT) 26th Annual Meeting, Poster Presentation #1691

Presentations

View All